Company news

Marizyme, Inc. news in 2021

Marizyme, Inc.'s news releases, calls and decks from 2021, newest first.

View company

Marizyme Announces the Closing of My Health Logic Acquisition Along With Initial Financing

December 23, 2021

Marizyme Inc. Announces Results of GOAL Study Presented at 7th Annual International Coronary Congress

December 3, 2021

Marizyme Announces Expansion of Patent Portfolio Into Several Key Territories

December 3, 2021

Marizyme is Pleased to Announce the Appointment of David Barthel as CEO

November 16, 2021

Marizyme, Inc. Issues Letter to Shareholders

March 31, 2021

Marizyme Announces New Distribution and Channel Partnership for Chilean Market with Abdera

March 4, 2021

Marizyme, Inc. Appoints Veteran Business Executive Julie Kampf to Board

February 4, 2021

Marizyme, Inc. Strengthens Senior Management Team with Two Appointments: Roger Schaller EVP, Commercial Operations and Amy Chandler, EVP, Regulatory Affairs and Quality Management Systems

February 1, 2021

Marizyme Announces Approval for DuraGraft® in India

January 14, 2021

Marizyme Announces the Use of DuraGraft® as the Standard-of-Care in Patients Undergoing Coronary Artery Bypass Surgery (CABG) at Vienna Heart Center North Floridsdorf

January 11, 2021

Marizyme, Inc. to Present at Biotech Showcase 2021 During the J.P. Morgan Healthcare Conference Biotech Showcase Digital, BIO @ JPM During "J.P. Morgan Week 2021"

January 7, 2021

Decks in 2021